Chapter 15. Uric Acid Alterations in Cardiometabolic Disorders and Gout

  1. Prof. Peter J. O'Brien2 and
  2. Prof. W. Robert Bruce3,4
  1. Renato Ippolito,
  2. Ferruccio Galletti and
  3. Pasquale Strazzullo

Published Online: 25 JAN 2010

DOI: 10.1002/9783527628100.ch15

Endogenous Toxins: Targets for Disease Treatment and Prevention

Endogenous Toxins: Targets for Disease Treatment and Prevention

How to Cite

Ippolito, R., Galletti, F. and Strazzullo, P. (2009) Uric Acid Alterations in Cardiometabolic Disorders and Gout, in Endogenous Toxins: Targets for Disease Treatment and Prevention (eds P. J. O'Brien and W. R. Bruce), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. doi: 10.1002/9783527628100.ch15

Editor Information

  1. 2

    University of Toronto, Graduate Department of Pharmaceutical Sciences, Faculty of Pharmacy, Room 1004, College Street 144, Toronto, ON M5S 3M2, Canada

  2. 3

    University of Toronto, Fitz Gerald Building, Room 342, College Street 150, Toronto, ON M5S 3E2, Canada

  3. 4

    University of Toronto, Department of Nutritional Sciences, Faculty of Medicine, Toronto, Ontario M5S 2E3, Canada

Author Information

  1. University of Naples, Department of Clinical and Experimental Medicine, Federico II Medical School, Via S. Pansini 5, 80131 Naples, Italy

Publication History

  1. Published Online: 25 JAN 2010
  2. Published Print: 21 OCT 2009

ISBN Information

Print ISBN: 9783527323630

Online ISBN: 9783527628100

SEARCH

Keywords:

  • uric acid;
  • hyperuricemia;
  • hypouricemia;
  • metabolic syndrome;
  • gout;
  • serum uric acid;
  • cardiovascular disease

Summary

This chapter contains sections titled:

  • Introduction

  • Dual Properties of Uric Acid as Antioxidant or Pro-Oxidant Molecule

  • Effects of Uric Acid on the Arterial Wall Properties and Endothelial Function

  • Causes of Hyperuricemia and Hypouricemia

  • Hyperuricemia, Gout, and Their Treatment

  • Uric Acid and Cardiovascular Disease

  • References